The growth of population health in Europe

Published on February 23, 2023

Developments in population health in the recent years had a lasting impact on the healthcare sector, influencing policy, drug development and access, commercial health management, and digital innovations.

As such, we believe that population health will become a key feature in the next 5 years, influencing policy, drug development and access, commercial health management, and digital innovations.

However, the term “population health” can mean many things. So, what does it mean to European payers and stakeholders, and how will this new focus change the perception of what constitutes “value” in the healthcare and life sciences sector in the future?

In this paper we explore the enablers for this shift, what it will mean for manufacturers and health providers, and how they can start preparing for market changes. We believe that these developments will have a major impact on population health and make it a key feature for the future.

 

Continue reading on website
Other news

Positioning Your Company for Growth in an Uncertain Economy

February 23, 2023
Overview: Uncertain times call for an actionable commercial plan. When markets are unstable, the temptation is to focus solely on minimizing risk factors. But looking beyond this, volatility also creates an opportunity for companies with a growth mindset. Is your business ready to face a downturn? In this webinar, we’ll explore what it means to respond to a recession such as responding to changing

Pharma: Brand planning season starts now!

February 23, 2023
Every year, healthcare companies go through the same procedures developing brand plans for their products.However, despite the yearly repetition, processes, expectations, and templates are often not quite as aligned as some would think. Based on our survey of 73 brand planning experts across the globe (marketing VPs, marketing directors, brand managers, etc.) we identified five key topics that hea